OC
GCVRZ

Oppenheimer & Co’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Oppenheimer & Co’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-18,979
Closed -$3K – 1468
2015
Q3 		$3K Sell
18,979
-9,490
-33% -$3.23K ﹤0.01% 1345
2015
Q2 		$19K Sell
28,469
-600
-2% -$415 ﹤0.01% 1462
2015
Q1 		$20K Sell
29,069
-300
-1% -$210 ﹤0.01% 1470
2014
Q4 		$23K Hold
29,369
– – ﹤0.01% 1382
2014
Q3 		$14K Hold
29,369
– – ﹤0.01% 1404
2014
Q2 		$14K Sell
29,369
-200
-0.7% -$97 ﹤0.01% 1398
2014
Q1 		$9K Sell
29,569
-250
-0.8% -$93 ﹤0.01% 1397
2013
Q4 		$10K Buy
29,819
+3,838
+15% +$4.64K ﹤0.01% 1373
2013
Q3 		$53K Sell
25,981
-361
-1% -$688 ﹤0.01% 1278
2013
Q2 		$50K Buy
+26,342
New +$46.3K ﹤0.01% 1236

Other funds holding GCVRZ

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Oppenheimer & Co's GCVRZ Position: Q4 2015 in Review

Oppenheimer & Co sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 18,979 shares — an estimated $3K sold.

Oppenheimer & Co first reported a position in GCVRZ in Q2 2013 and held it in 10 quarters. The position peaked at $53K in Q3 2013. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • Oppenheimer & Co reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 18,979 Sanofi Contingent Value Rights shares in Q4 2015, an estimated $3K.
  • Oppenheimer & Co first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 10 quarters.
  • Oppenheimer & Co's Sanofi Contingent Value Rights position peaked at $53K in Q3 2013.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.